Kythera, Bayer tout PhIII results on ATX-101; Mouse study indicates potential of stroke treatment;

 @FierceBiotech: The Biggest R&D Spenders In Biopharma. Special Report | Follow @FierceBiotech

 @JohnCFierce: AVI's retake on IIb DMD data looks to me like a second attempt at a good first impression. Release | Follow @JohnCFierce

 @RyanMFierce: Perakslis: FDA plans to open up some of the FDA's liver tox data on >2000 drugs to outside parties. A good example of data sharing. | Follow @RyanMFierce

> Kythera and Bayer announced the "successful completion of two pivotal European Phase III clinical trials with ATX-101, an injectable drug for the reduction of unwanted fat under the chin. Release

> Repligen ($RGEN) says it successfully wrapped a Phase I study to evaluate the pharmacokinetic and safety profile of RG3039, a candidate for spinal muscular atrophy. Release

> RainTree Oncology, which provides oral oncology drug acquisition and management services, has closed an $11.1 million round. Robert M. Bass is the lead investor. Release

Pharma News

 @FiercePharma: Zyprexa sales fell off a (patent) cliff, but Lilly still beat analyst forecasts for Q1--Reuters. News | Follow @FiercePharma

> GSK scrapes up 2% sales growth despite politics, generics. Article

> Spurned GSK chief: We're the 'compelling owner' for HGS. Story

Medical Devices News

@FierceMedDev: BioMérieux Q1 2012 sales soar, propelled by China, India. Story | Follow @FierceMedDev

> Medtronic bets IT enhancements will boost revenue. Item

> Expanded use for Edwards' Sapien heart valve faces FDA delay. More

> Analytical instruments, specialty diagnostics drive Thermo Fisher Q1 sales. Article

Drug Delivery News

 @DamianFierce: Tamarisk plans to "turn the industry upside down" with oral insulin platform. News | Follow @DamianFierce

> 'Chemo bomb' nanotechnology effective in halting tumors. Story

> SkyePharma's inhaler takes step toward EMA approval. Article

> Scottish scientists take a page from sci-fi with sonic screwdriver. More

> Australia jumps into life sciences fray with R&D tax credit. Piece

Biomarkers News

> Autism Awareness Month and autism biomarkers. Commentary

> Novo Nordisk, Oxford University seeking inflammation markers. More

> Urine biomarker test for autism on the horizon? Story

> 'Landmark' study splits breast cancer into 10 types. News

And Finally… A team of investigators says that it has gathered promising animal data in a mouse study of a new drug to treat stroke damage. Story

 

Suggested Articles

As Relay looks to enter the clinic in 2020, the company is adding a trio of biopharma vets to its leadership team.

A phase 3 trial of Myovant Sciences’ relugolix in prostate cancer has met its primary endpoint, teeing the company up to file for FDA approval.

The Medicines Company, fresh from its turn at the AHA this weekend, has seen its shares jump on growing rumors that Novartis wants to acquire it.